1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Immunotherapy Drugs Market By Drug Type, By Application, By End User, And By Region (Global Market Forecast To 2027)

Global Market Analysis Of Immunotherapy Drugs Market By Drug Type, By Application, By End User, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 125 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Immunotherapy Drugs market is estimated at $ 145.5 billion in 2019, and expected to reach $ 347.59 billion by 2027, with a CAGR of 11.5% from 2020 to 2027.

Immunotherapy is a medical treatment therapy that mainly uses substances to stimulate or depress the immune system to help the body to fight against cancer, infection, and other diseases.

Market Dynamics

The Global Immunotherapy Drugs market is primarily driven by factors such as the growing occurrences of chronic diseases, targeted diseases and lifestyle disorders; growing demand for immunotherapy drugs over conventional treatments; growing preferences for monoclonal antibodies and biosimilars; growing investment in healthcare infrastructure; growing focus on research and development; growing cases of inflammatory and autoimmune diseases; are some of the market dynamics.

Market Segmentation

The Global Immunotherapy Drugs Market is mainly classified based on Drug Type, Application, End User, and Region.

  • Based on Drug Type, the market is further segmented into Monoclonal Antibodies, Vaccines, Interferons & Interleukins, Checkpoint Inhibitors, and Other Immunotherapies
  • Based on Application, the market is further segmented into Infectious Disease, Cancer, Autoimmune & Inflammatory Diseases, and Other Applications
  • Based on End User, the market is further segmented into Hospitals, Clinics, Cancer Research Centers, and Other Users

Regional Analysis

Based on geography, the Global Immunotherapy Drugs market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa                                                                                       

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape                     

Global Immunotherapy Drugs Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Immunotherapy Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Immunotherapy Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Global Immunotherapy Drugs are Boehringer Ingelheim, AbbVie, Sanofi, Novartis International AG, Pfizer, F. Hoffmann-La Roche, Merck & Co., Johnson & Johnson, GSK, Amgen, AstraZeneca, Incyte Corporation, Bayer AG, NBE Therapeutics, Biontech SE, Immatics Biotechnologies GmbH, Eli Lilly and Company, Genmab, Gilead Sciences, Teva Pharmaceuticals, Bristol-Myers Squibb, and other prominent players.

Immunotherapy Drugs Market Key Segments:

By Drug Type    

  • Monoclonal Antibodies
  • Vaccines
  • Interferons & Interleukins
  • Checkpoint Inhibitors
  • Other Immunotherapies

By Application   

  • Infectious Disease
  • Cancer
  • Autoimmune & Inflammatory Diseases
  • Other Applications

By End User

  • Hospitals
  • Clinics
  • Cancer Research Centers
  • Other Users

By Region             

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

 

1 Market Overview

1.1 Immunotherapy Drugs Introduction

1.2 Market Analysis by Drug Type

 1.2.1 Overview: Global Immunotherapy Drugs Revenue by Drug Type: 2019 VS 2021 VS 2027

1.2.2 Monoclonal Antibodies

1.2.3 Vaccines

 1.2.4 Interferons & Interleukins

 1.2.5 Checkpoint Inhibitors 1.2.6 Other Immunotherapies

 1.3 Market Analysis by Application

 1.3.1 Overview: Global Immunotherapy Drugs Revenue by Application: 2019 VS 2021 VS 2027

1.3.2 Infectious Disease 1.3.3 Cancer

1.3.4 Autoimmune & Inflammatory Diseases

 1.3.5 Other Applications

1.4 Market Analysis by End User

 1.4.1 Overview: Global Immunotherapy Drugs Revenue by End User: 2019 VS 2021 VS 2027

1.4.2 Hospitals

1.4.3 Clinics

 1.4.4 Cancer Research Centers

1.4.5 Other Users

1.5 Overview of Global Immunotherapy Drugs Market

1.5.1 Global Immunotherapy Drugs Market Status and Outlook (2019-2027)

1.5.2 North America (United States, Canada and Mexico)

1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.5.5 South America, Middle East & Africa

1.6 Market Dynamics

1.6.1 Market Opportunities

1.6.2 Market Risk

1.6.3 Market Driving Force

2 Manufacturers Profiles

2.1 Boehringer Ingelheim

2.1.1 Boehringer Ingelheim Details

2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Boehringer Ingelheim SWOT Analysis

2.1.4 Boehringer Ingelheim Product and Services

2.1.5 Boehringer Ingelheim Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 AbbVie

2.2.1 AbbVie Details

2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 AbbVie SWOT Analysis

2.2.4 AbbVie Product and Services

2.2.5 AbbVie Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Sanofi SWOT Analysis

2.3.4 Sanofi Product and Services

2.3.5 Sanofi Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Novartis International AG 

2.4.1 Novartis International AG Details

2.4.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Novartis International AG SWOT Analysis

2.4.4 Novartis International AG Product and Services

2.4.5 Novartis International AG Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Pfizer SWOT Analysis

2.5.4 Pfizer on Product and Services

2.5.5 Pfizer Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 F. Hoffmann-La Roche

2.6.1 F. Hoffmann-La Roche Details

2.6.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 F. Hoffmann-La Roche SWOT Analysis

2.6.4 F. Hoffmann-La Roche Product and Services

2.6.5 F. Hoffmann-La Roche Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Merck & Co.

2.7.1 Merck & Co. Details

2.7.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Merck & Co. SWOT Analysis

2.7.4 Merck & Co. Product and Services

2.7.5 Merck & Co. Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Johnson & Johnson

2.8.1 Johnson & Johnson Details

2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Johnson & Johnson SWOT Analysis

2.8.4 Johnson & Johnson Product and Services

2.8.5 Johnson & Johnson Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 GSK

2.9.1 GSK Details

2.9.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 GSK SWOT Analysis

2.9.4 GSK Product & Services

2.9.5 GSK Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.10 Amgen 

2.10.1 Amgen Details

2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Amgen SWOT Analysis

2.10.4 Amgen Product & Services

2.10.5 Amgen Immunotherapy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Immunotherapy Drugs Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Immunotherapy Drugs Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Immunotherapy Drugs Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Immunotherapy Drugs Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Immunotherapy Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Immunotherapy Drugs Sales and Market Share by Regions (2019-2020)

4.1.2 Global Immunotherapy Drugs Revenue and Market Share by Regions (2019-2020)

4.2 North America Immunotherapy Drugs Sales and Growth Rate (2019-2020)

4.3 Europe Immunotherapy Drugs Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific Immunotherapy Drugs Sales and Growth Rate (2019-2020)

4.5 South America Immunotherapy Drugs Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa Immunotherapy Drugs Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America Immunotherapy Drugs Sales, Revenue and Market Share by Country

5.1.1 North America Immunotherapy Drugs Sales and Market Share by Country (2019-2020)

5.1.2 North America Immunotherapy Drugs Revenue and Market Share by Country (2019-2020)

5.2 United States Immunotherapy Drugs Sales and Growth Rate (2019-2020)

5.3 Canada Immunotherapy Drugs Sales and Growth Rate (2019-2020)

5.4 Mexico Immunotherapy Drugs Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe Immunotherapy Drugs Sales, Revenue and Market Share by Country

6.1.1 Europe Immunotherapy Drugs Sales and Market Share by Country (2019-2020)

6.1.2 Europe Immunotherapy Drugs Revenue and Market Share by Country (2019-2020)

6.2 Germany Immunotherapy Drugs Sales and Growth Rate (2019-2020)

6.3 UK Immunotherapy Drugs Sales and Growth Rate (2019-2020)

6.4 France Immunotherapy Drugs Sales and Growth Rate (2019-2020)

6.5 Russia Immunotherapy Drugs Sales and Growth Rate (2019-2020)

6.6 Italy Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Immunotherapy Drugs Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Immunotherapy Drugs Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific Immunotherapy Drugs Revenue and Market Share by Regions (2019-2020)

7.2 China Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7.3 Japan Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7.4 Korea Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7.5 India Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7.6 Southeast Asia Immunotherapy Drugs Sales and Growth Rate (2019-2020)

7.7 Australia Immunotherapy Drugs Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America Immunotherapy Drugs Sales, Revenue and Market Share by Country

8.1.1 South America Immunotherapy Drugs Sales and Market Share by Country (2019-2020)

8.1.2 South America Immunotherapy Drugs Revenue and Market Share by Country (2019-2020)

8.2 Brazil Immunotherapy Drugs Sales and Growth Rate (2019-2020)

8.3 Argentina Immunotherapy Drugs Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Immunotherapy Drugs Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Immunotherapy Drugs Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa Immunotherapy Drugs Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia Immunotherapy Drugs Sales and Growth Rate (2019-2020)

9.3 Turkey Immunotherapy Drugs Sales and Growth Rate (2019-2020)

9.4 Egypt Immunotherapy Drugs Sales and Growth Rate (2019-2020)

9.5 South Africa Immunotherapy Drugs Sales and Growth Rate (2019-2020)

10 Global Immunotherapy Drugs Market Segment by Drug Type

10.1 Global Immunotherapy Drugs Sales Market Share by Drug Type (2019-2020)

10.2 Global Immunotherapy Drugs Revenue Market Share by Drug Type (2019-2020)

10.3 Global Immunotherapy Drugs Price by Drug Type (2019-2020) 11 Global Immunotherapy Drugs Market Segment by Application

11.1 Global Immunotherapy Drugs Sales Market Share by Application (2019-2020)

11.2 Global Immunotherapy Drugs Revenue Market Share by Application (2019-2020)

11.3 Global Immunotherapy Drugs Price by Application (2019-2020) 12 Global Immunotherapy Drugs Market Segment by End User

12.1 Global Immunotherapy Drugs Sales Market Share by End User (2019-2020)

12.2 Global Immunotherapy Drugs Revenue Market Share by End User (2019-2020)

12.3 Global Immunotherapy Drugs Price by End User (2019-2020) 13 Market Forecast

13.1 Global Immunotherapy Drugs Sales, Revenue and Growth Rate (2021-2027)

13.2 Immunotherapy Drugs Market Forecast by Regions (2021-2027)

13.2.1 North America Immunotherapy Drugs Market Forecast (2021-2027)

13.2.2 Europe Immunotherapy Drugs Market Forecast (2021-2027)

13.2.3 Asia-Pacific Immunotherapy Drugs Market Forecast (2021-2027)

13.2.4 South America Immunotherapy Drugs Market Forecast (2021-2027)

13.2.5 Middle East & Africa Immunotherapy Drugs Market Forecast (2021-2027)

13.3 Immunotherapy Drugs Market Forecast by Drug Type (2021-2027)

13.3.1 Global Immunotherapy Drugs Sales Forecast by Drug Type (2021-2027)

13.3.2 Global Immunotherapy Drugs Market Share Forecast by Drug Type (2021-2027)

13.4 Immunotherapy Drugs Market Forecast by Application (2021-2027)

13.4.1 Global Immunotherapy Drugs Sales Forecast by Application (2021-2027)

13.4.2 Global Immunotherapy Drugs Market Share Forecast by Application (2021-2027) 13.5 Immunotherapy Drugs Market Forecast by End User (2021-2027)

13.5.1 Global Immunotherapy Drugs Sales Forecast by End User (2021-2027)

13.5.2 Global Immunotherapy Drugs Market Share Forecast by End User (2021-2027)

14 Sales Channel, Distributors, Traders and Dealers

14.1 Sales Channel

14.1.1 Direct Marketing

14.1.2 Indirect Marketing

14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Data Source

16.3 Disclaimer

16.4 About Us

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets